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Members of the British Paediatric Neurology Association were invited to participate in a national audit of children presenting 
with a possible diagnosis of epilepsy. The audit was based on a ‘standard’ or set of pre-determined questions drawn up by 
an advisory audit group. The audit form comprised a total of 30 questions divided into four sections addressing history, 
examination, investigation, treatment and communication. Information for the audit was obtained retrospectively from the 
child’s case notes. Each participating centre or consultant was asked to audit the case notes of 20 children. At the end of 
the 12-month recruitment period three centres responded, contributing audit forms on 50 children. The required information 
was provided for the majority of the questions in each of the four sections, thereby meeting the audit ‘standard’. Within the 
history section, only 32 of the 50 (64%) case notes had recorded whether or not there was ‘any obvious provoking factor or 
circumstance to the episodes’. Communication was the least satisfactorily completed section with between none and 48% of 
the case notes documenting that the child’s family had been informed of the existence of a voluntary epilepsy organization. 
Despite the simplicity of the audit form, the response for this national audit was considerably lower than anticipated. 
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INTRODUCTION 
The primary objective of this audit was to identify if 
a ‘standard’, or set of pre-determined criteria, were 
being met when assessing children presenting with 
suspected epilepsy at their first new patient outpa- 
tient visit, and specifically whether an adequate his- 
tory was obtained when diagnosing and classifying 
epilepsy. An additional aim was to assess the level of 
information within the medical case notes addressing 
issues including investigations, treatment and com- 
munication. This ‘standard’ or set of pre-determined 
questions was drawn up by an epilepsy audit group 
which included the late Professor Anthony Hopkins, 
Research Director at the Royal College of Physicians 
(London). 
MATERIALS AND METHODS 
The audit form was piloted amongst five centres in- 
volving both general paediatricians and paediatric 
neurologists. All involved in the pilot were asked to 
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comment on the audit form including suggesting any 
amendments or additions. The audit was primarily 
aimed at consultant paediatric neurologists but the 
whole membership of the British Paediatric Neurol- 
ogy Association (BPNA) were informed of the audit, 
initially by an announcement at the Annual Meeting 
of the BPNA and subsequently in two newsletters 
distributed to the membership of the BPNA. Those 
interested in participating in the audit were asked to 
write to the audit/guidelines secretary of the BPNA 
(REA) for copies of the audit form. 
The required information for the audit was designed 
to be obtained retrospectively from reviewing the 
child’s case notes, using either the hand-written med- 
ical entries or from typed correspondence, or both. 
It was suggested that the audit of the case notes 
could be undertaken by any one of the following: 
the consultant; a junior member of medical staff; 
a nurse (a clinical nurse specialist in epilepsy; a 
clinical trials nurse or epilepsy/neurology outpatient 
nurse); an audit assistant (if one was available); or 
the epilepsy/neurology secretary. In the initial pilot 
involving 50 patients from five centres, the audit was 
undertaken twice and independently by two people- 
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the consultant and ‘another’ (from the list described 
above). The purpose of this duplicate audit was to as- 
sess concordance between the two auditors and their 
level of agreement in identifying and collating the 
required information. The results of this pilot demon- 
strated that there was concordance in almost 90% of 
the majority of the audit questions. In view of this it 
was felt reasonable and appropriate that in the main 
study the audit process could be undertaken once, by 
any of the people listed above. 
Each participating consultant/centre was asked to 
audit 20 patients’ case notes. Results were analysed 
according to an individual centre’s performance (in 
meeting the ‘standard’) and also how each centre’s 
performance compared to other participating centres. 
Analysis was undertaken in the Clinical Audit depart- 
ment at Alder Hey Children’s Hospital in Liverpool. 
A copy of the audit form is shown in Appendix 1. 
Questions 1.1-1.5 and 2 were designed to try and 
identify background information about the nature, du- 
ration and frequency of the episodes or events and to 
determine whether the episodes were considered to 
be epileptic, non-epileptic or of uncertain origin. 
Questions 3 and 4 were asked to identify both the 
seizure type or types and, if possible, the type of 
epilepsy. The specific epilepsy syndrome was not re- 
quested in an attempt to simplify the audit form- 
particularly in view of the intended future use of the 
form amongst general paediatricians. It was assumed 
that all participants in the audit would have a knowl- 
edge of the International League Against Epilepsy 
(ILAE) seizure (198 1) and epilepsy (1989) ciassifica- 
tions. 
Questions 5 and 6 were asked to obtain some in- 
formation about the child’s neurological and develop- 
mental status and, when relevant, educational ability 
and progress. 
Questions 7-9 focused on the most appropriate and 
relevant investigations. It was not expected that all 
patients would have had an EEG or brain scan (CT or 
MRI) at the time of the first clinic visit; the decision 
to arrange or undertake these tests should arguably 
have been made after the initial visit depending on 
the clinical history. 
Question 10 was to determine if there was informa- 
tion on whether an antiepileptic drug was prescribed, 
and in what dose, and whether the family was in- 
formed of any potential side-effects of these drugs. 
Questions 11 and 12 focused on communication, 
and specifically on who would be responsible for the 
follow-up of the child and if the family was informed 
of the existence of either a local or national voluntary 
epilepsy association (e.g. the British Epilepsy Asso- 
ciation, Epilepsy Association of Scotland or the Na- 
tional Society for Epilepsy). 
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RESULTS 
Nine centres expressed an interest in participating in 
the audit and requested copies of the audit form. 
Twelve months later following this initial expres- 
sion of interest, 50 completed audit forms were re- 
turned from three centres, one in each of England, 
Scotland and Ireland. The results for all 50 patients’ 
forms are summarized in Table 1. Table 2 compares 
the results of the audits for each centre. The total 
membership of the BPNA and those who received 
a newsletter informing them of the audit (and there- 
fore inviting participation) was approximately 150. 
However, the potential number of participants would, 
in reality, be considerably less (approximately loo), 
because of obvious ‘exclusions’, including special- 
ist registrars, overseas members and others having 
predominantly non-clinical appointments (e.g. neu- 
rophysiologists and neuroradiologists). Therefore the 
response rate for this audit was estimated to be 3%. 
History and examination 
(1.1) 
(1.2) 
(1.3) 
(1.4) 
(1.5) 
Age at onset: 42 cases (84%) had a record of 
the age at onset of the episodes. 
Sequence of events during the episode: 48 cases 
(96%) had a record of the sequence of events 
during the episode(s). 
Duration of each type of episode: 43 cases 
(36%) had a record of the duration of the 
episodes; one family was unable to provide this 
information. 
Frequency of the episode(s): 45 cases (90%) 
had a record of the frequency of the episodes. 
Presence/absence of any provoking/relieving 
factors: 32 cases (64%) had a record of pro- 
voking or relieving factors. 
(2) Nature of the episode(s): 
(a) epileptic: 45 cases (90%) were considered 
to be epileptic in origin. 
(b) non-epileptic: none of the cases were con- 
sidered to be non-epileptic in origin. 
(c) uncertain origin: five cases (10%) had an 
uncertain diagnosis. 
(3) Seizure gpefs] in patients where the episodes 
were considered to be epileptic (n = 45): in 
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Table 1: Summary of results (N = 50) 
Was there a record of: 
I.1 Age at onset of the episode? 
Sequence of events during the episode? 
The duration of each episode? 
The frequency of the episodes? 
The presence or absence of any provoking or relieving factors? 
Was the attack considered to be: 
epileptic 
non-epileptic 
uncertain 
No. of records (%) 
42 84 
491 
1.2 
1.3 
1.4 
1.5 
48 96 
43 86 
45 90 
32 64 
2a 
2b 
2c 
3 
45 
0 
5 
44 
90 
10 
88 
4a 
4b 
4c 
4d 
4e 
4f 
4g 
5a 
5b 
6 
7 
8 
9 
10a 
IOb 
IOC 
II 
Was the seizure type or types identified? 
Was the diagnosis: 
Primary (idiopathic) generalized epilepsy (including juvenile 
myoclonic and typical absence epilepsy) 
Symptomatic generalized epilepsy (including Lennox-Gastaut Syndrome) 
Benign partial epilepsy 
Myoclonic epilepsy 
Infantile spasms 
Partial seizures (< 1 seizure/month) 
Partial seizures (> 1 seizure/month) 
Other diagnosis 
Not identified 
No answer 
Was there a statement on the child’s neurological development in the first 2 years of life? 
If of school age (N = 39) was there a statement on school performance and progress? 
Was there a statement on the child’s physical examination and neurological development? 
Was an EECi either ordered or already available? 
Was a CT scan either ordered or already available? 
Was an MRl scan either ordered or already available? 
The current antiepileptic treatment (whether prescribed previously or initiated at this visit) 
The dose or doses of these antiepileptic drugs 
The discussion of possible side-effects of any other antiepileptic drugs newly prescribed at this visit 
Was there a statement on whether the family were informed of the existenceof a local or national 
voluntary epilepsy association? 
6 12 
3 6 
I 2 
I 2 
I 2 
6 12 
19 38 
3 6 
5 10 
5 10 
35 70 
31 19 
48 96 
50 100 
22 44 
23 46 
42 84 
42 84 
12 24 
12 24 
12 Was there a statement on who is to be responsible for the continuing follow-up of the child? 50 100 
four cases the child was diagnosed as hav- 
ing epilepsy but it was not possible to iden- 
tify the specific seizure type. Two children had 
a seizure type that was not listed on the audit 
form-one with photoconvulsive epilepsy and 
one diagnosed as ‘petit mal’ but not included 
in the primary (idiopathic) generalized epilepsy 
category. In one case the question was not an- 
swered. 
(4) Specific epilepsy diagnoses: 
(a) primary (idiopathic) generalized epilepsy: 
six children (12%); 
(b) symptomatic generalized: three children 
(6%); 
(c) benign partial epilepsy: one child; 
(d) myoclonic epilepsy: one child; 
(e) infantile spasms: one child; 
(f) partial seizures (<l/month): six children 
(12%); and 
(54 
(5b) 
(6) 
(g) partial seizures (> l/month): 19 children 
(38%) were diagnosed with this category. 
Three other seizure ‘types’ were also iden- 
tified, one each with ‘photoconvulsive gen- 
eralized epilepsy’, ‘petit mal’ and a ‘com- 
plicated febrile convulsion’. 
Child’s neurological development in the first 
two years of life: 35 cases (70%) had a state- 
ment about the child’s neurological develop- 
ment. In four cases the question had not been 
answered. 
Child’s school pe$ormance and progress: in 3 1 
cases (79%) of the 39 children who were of 
school age, there was a statement on their aca- 
demic ability. 
Child’s physical examination and neurological 
development: 48 cases (96%) had a statement 
on the child’s physical examination and neuro- 
logical development. 
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DISCUSSION 
(7) EEG: all 50 cases (100%) had either already 
had or were about to have, an EEG. 
(8) CT: 22 cases (44%) had undergone or were 
about to have, a CT head scan. 
(9) MRI: 23 cases (46%) had undergone or were 
about to have, an MRI head scan. 
It was not possible to identify which, if any patients 
had undergone, or were to have both CT and MRI. 
Treatment 
(1 Oa) Current antiepileptic treatment: 42 cases (84%) 
had a statement on the current drug treatment; 
the question was unanswered in seven cases. 
(lob) Dose(s) of the antiepileptic drug(s): 42 cases 
(84%) had a comment on this; it was unan- 
swered in seven. 
(10~) Discusion of side-efsects: 12 cases (24%) had a 
statement that side-effects had been discussed 
with the family and the quesion was unan- 
swered in six. One questionnaire stated that 
although medication had not yet been started, 
potential side-effects had been discussed. 
Communication 
(11) Informing families of voluntary epilepsy 
associations: 12 questionnaires (24%) indicated 
that the family had been informed about the ex- 
istence of either a national or local voluntary 
epilepsy association. In addition, in seven cases 
where the answer had been ‘no’, a comment 
was made that the family had been informed 
that a fieldworker from the relevant local volun- 
tary association would be present at all clinics, 
and in five of these seven the family had met 
the fieldworker. 
(12) Continuing follow-up: all 50 forms (100%) in- 
cluded a statement identifying who would be 
responsible for the child’s follow-up. 
Overall, the results for each centre demonstrated 
similar response rates in many areas (Table 2), al- 
though there were exceptions, specifically in Centre A 
where there appeared to be a lower response rate in 
a number of areas. 
Clinical audit assesses clinical practice against agreed 
standards and is an integral part of clinical practice 
and clinical effectiveness. It is also an educational 
process that aims to improve patient carelm3. The ob- 
jectives and aims of this audit were based on these 
premises. The primary purpose of this audit was to 
try and determine if the appropriate information was 
being obtained when assessing a child presenting with 
suspected epilepsy in order to correctly diagnose both 
epilepsy and also the seizure type/epilepsy syndrome. 
Secondary aims included a brief assessment of the 
level of information recorded within the medical case 
notes on areas including investigation, treatment and 
communication. 
It was anticipated that the response to the audit 
would be relatively modest but the actual response 
was lower than predicted. There may be many reasons 
for this but arguably the most likely explanation is a 
general reluctance to participate in a nationally-based 
‘audit’. The audit form was specifically designed to 
be both brief and simple, in order to maximize partic- 
ipation. No significant changes to the form were sug- 
gested following the pilot audit. Although possible, 
it is unlikely that the audit form itself significantly 
dissuaded clinicians from taking part. This is sup- 
ported by the fact that only nine clinicians expressed 
an initial interest (and therefore had the opportunity 
of seeing the form) and of these nine, 33% even- 
tually completed the audit. The number of patients’ 
case notes to be audited was not felt to be excessive 
and although it was initially felt that 10 patients per 
centre would be sufficient, 20 was subsequently con- 
sidered to be a more appropriate number with which 
to undertake a meaningful audit. Finally, it was made 
clear that the audit could be performed by any one of 
a number of different professionals, again to facilitate 
its completion. 
The ‘history and examination’ section of the audit 
was generally satisfactorily completed apart from two 
areas-the presence or absence of any provoking or 
relieving factors (64%) and the child’s early neuro- 
logical development (70%). The identification of fac- 
tors which provoke or relieve a child’s paroxysmal 
episodes is clearly important, not only in clarifying 
their aetiology but also in possibly influencing their 
management. 
All children had undergone, or were about to un- 
dergo an EEG, and the majority had been, or were 
about to be, scanned with either CT or MRI. Given 
that not all children in the audit had a diagnosis of 
epilepsy and a number of those who did had an idio- 
pathic generalized epilepsy (for which imaging is not 
usually indicated) it would appear as though a number 
of children were inappropriately investigated. How- 
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ever, it is not known whether EEG or CT/MRI (or 
both) had been performed/ordered (by another clini- 
cian, including in another hospital), before the child 
was seen in the epilepsy clinic which formed the basis 
of the audit. 
Over 90% of audit forms included a comment on 
the child’s current antiepileptic treatment, including 
doses. It was not possible to identify from the form 
precisely how many of the children were prescribed a 
new or different antiepileptic drug at the ‘audit’ visit 
and therefore the interpretation of the extent to which 
families were informed of the potential side-effects of 
the drug(s) cannot be determined. 
In terms of communication, all forms stated who 
was to be responsible for the continuing follow-up 
of the child. However, only 24% of patients were in- 
formed about the existence of a voluntary epilepsy 
association. Even if one accepts that this would not 
be necessary for a significant number of children (be- 
cause they may not have had epilepsy), it is still dis- 
appointingly low. The availability of a nurse special- 
ist in epilepsy or a fieldworker (from a local volun- 
tary epilepsy support group, as used by one of the 
centres participating in this audit) is not ubiquitous 
and the national voluntary associations, such as the 
British Epilepsy Association or National Society for 
Epilepsy, are not only valuable sources of informa- 
tion and advice, but exist specifically to serve patients 
with epilepsy and their families. 
It is difficult if not impossible to draw any meaning- 
ful conclusions from this audit, largely because of the 
very small number of participating centres. For sim- 
ilar reasons it is inappropriate to over-interpret per- 
formances between centres. Finally, the audit circle 
has not been completed, whereby the process could 
(should ?) be repeated in these participating centres 
following the dissemination of these initial results. 
However, as this audit has shown, there is little en- 
thusiasm for the audit process and, for at least two 
centres, one could argue that there would appear to be 
little justification in repeating the exercise because of 
the 90-100% response rates achieved in most sections 
of the first audit. 
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APPENDIX 1: AUDIT FORM FOR CHILDREN 
REFERRED WITH SUSPECTED EPILEPSY 
(NEW PATIENT; FIRST VISIT; REFERRAL 
FROM ANY SOURCE) 
History and examination 
(1) Was there a written description of the episode 
or episodes containing information on the foi- 
lowing: 
(1 .l) age at onset of the episode(s) 
(1.2) the sequence of events during the 
episode(s) 
(1.3) the duration of each episode 
(1.4) the frequency of the episode(s) 
( 1.5) the presence or absence of any provoking 
or relieving factors or circumstances 
(2) Was there a statement on whether the episode(s) 
or attack(s) were considered to be: 
(a) epileptic or 
(b) non-epileptic or 
(c) uncertain 
(3) If  the episode(s) or attacks were diagnosed as 
epileptic seizures was the seizure type or types 
identified. 
(4) Were any of the following diagnoses made: 
(a) primary generalized epilepsy (including 
juvenile myoclonic and typical absence 
epilepsy) 
(b) symptomatic generalized epilepsy (includ- 
ing the Lennox-Gastaut syndrome) 
(c) benign partial epilepsy 
(d) myoclonic epilepsy 
(e) infantile spasms 
(f) partial seizures (< 1 seizure/month) 
(g) partial seizures (> 1 seizure/month) 
An audit of children referred with suspected epilepsy 
(5). Was there a statement on: 
(a) the child’s neurological development in the 
first 2 years of life and 
(b) if of school age, was there a statement on 
school performance and progress 
(6). Was there a statement on the child’s physical 
examination and neurological examinations 
Investigation 
(7) Was an EEG either ordered or already available 
(8) Was a CT scan either ordered or already avail- 
able 
(9) Was an MRI scan either ordered or already 
available 
495 
Treatment 
(10) Was there a statement on: 
(a) the current antiepileptic drug treatment 
(whether prescribed previously or at that 
visit) 
(b) the dose or doses of these antiepileptic 
drugs 
(c) the discussion of possible side-effects of 
any other antiepileptic drugs newly pre- 
scribed at this visit 
Communication 
(11) Was there a statement on whether the family 
were informed of the existence of a local or na- 
tional voluntary epilepsy association 
(12) Was there a statement on who is to be respon- 
sible for the continuing follow-up of the child 
